Yes, miRNAs have shown great potential as biomarkers for cancer diagnosis, prognosis, and treatment response. Their stability in body fluids like blood and urine makes them attractive candidates for non-invasive diagnostic tests. For example, elevated levels of miR-155 in blood have been associated with poor prognosis in breast cancer patients.
